Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Merck & Co
(NY:
MRK
)
82.81
-2.34 (-2.75%)
Official Closing Price
Updated: 7:00 PM EDT, Sep 12, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Merck & Co
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
U.S. FDA Accepts New Drug Application for Merck’s Doravirine/Islatravir, an Investigational, Once-Daily, Oral, Two-Drug Regimen for Treatment of Adults with Virologically Suppressed HIV-1 Infection
July 10, 2025
From
Merck Sharp & Dohme
Via
Business Wire
Kazia Reports Over 50% Cancer Cell Reduction In Early Data From Breast Cancer Trial, Stock Jumps
July 09, 2025
Kazia's early trial data show significant CTC and cluster reduction in a breast cancer patient treated with Paxalisib, Keytruda, and chemotherapy.
Via
Benzinga
Nvidia's $4 Trillion Milestone Lifts Wall Street: What's Moving Markets Wednesday?
July 09, 2025
Wall Street rose on Wednesday as investors shrugged off fresh trade uncertainty after the White House delayed the start of new tariffs to Aug. 1, raising hopes for new rounds of negotiations.
Via
Benzinga
Topics
World Trade
P/E Ratio Insights for Merck & Co
July 09, 2025
Via
Benzinga
Explore the top gainers and losers within the S&P500 index in today's session.
July 09, 2025
Curious about the top performers within the S&P500 index in the middle of the day on Wednesday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.
Via
Chartmill
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Verona Pharma plc (Nasdaq - VRNA), Olo Inc. (NYSE - OLO), Guaranty Bancshares, Inc. (NYSE - GNTY), MRC Global Inc. (NYSE - MRC)
July 09, 2025
From
Brodsky & Smith LLC
Via
GlobeNewswire
Merck Strikes $10-Billion Deal For Verona, Secures First-In-Class COPD Drug
July 09, 2025
Merck is acquiring Verona Pharma for $10 billion, gaining COPD drug Ohtuvayre as part of its strategy to offset Keytruda's looming patent loss.
Via
Benzinga
Topics
Intellectual Property
Merck Plots $10 Billion Takeover Of COPD Drugmaker Verona Pharma
July 09, 2025
The takeover target just launched its first drug last summer. Shares have mostly trended higher since.
Via
Investor's Business Daily
Topics
Government
Merck To Acquire Verona For $10B In Bid To Expand Cardio-Pulmonary Pipeline
July 09, 2025
Merck will acquire Verona for $107 per American Depository Share (ADS), each of which represents eight Verona Pharma ordinary shares, for a total transaction value of approximately $10 billion.
Via
Stocktwits
Topics
Government
Merck to Acquire Verona Pharma, Expanding its Portfolio to Include Ohtuvayre® (ensifentrine), a First-In-Class COPD Maintenance Treatment for Adults and Expected to Drive Growth into the Next Decade
July 09, 2025
From
Merck & Co., Inc.
Via
Business Wire
Branded Pharmaceuticals Stocks Q1 Recap: Benchmarking Merck (NYSE:MRK)
July 08, 2025
As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the branded pharmaceuticals industry, including Merck (NYSE:MRK) and its peers.
Via
StockStory
Topics
Artificial Intelligence
Intellectual Property
Merck to Present New Data Highlighting Research Advancements Across its HIV Prevention and Treatment Pipeline at IAS 2025
July 08, 2025
From
Merck & Co., Inc.
Via
Business Wire
Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs
July 07, 2025
Via
Investor Brand Network
Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs
July 07, 2025
EQNX::TICKER_START (NYSE:CLDI),(NASDAQ:REGN),(NASDAQ:VRTX),(OTCQX:RHHBY),(NYSE:MRK) EQNX::TICKER_END
Via
FinancialNewsMedia
Topics
Death
Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones?
July 07, 2025
Via
The Motley Fool
Topics
Stocks
Trump's 'Big, Beautiful Bill' Hands $5 Billion Win To Big Pharma: Report
July 04, 2025
Trump's $3.3 trillion domestic agenda bill, passed by the House on Thursday, includes a significant victory for pharmaceutical companies .
Via
Benzinga
Topics
Government
2 S&P 500 Stocks with Promising Prospects and 1 to Question
July 04, 2025
The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth,...
Via
StockStory
Topics
Stocks
Uncover the latest developments among S&P500 stocks in today's session.
July 03, 2025
Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Thursday.
Via
Chartmill
AstraZeneca In $15B Talks For Drug That Could Upend Lung Cancer Treatment
July 03, 2025
Via
Benzinga
What's going on in today's session: S&P500 gap up and gap down stocks
July 03, 2025
Wondering which stocks are making significant price gaps? Explore the S&P500 index on Thursday to find the gap up and gap down stocks in today's session.
Via
Chartmill
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields
July 03, 2025
Via
Benzinga
Merck's Hypertension Drug On FDA Fast Track For Label Expansion
July 02, 2025
Merck's Winrevair gains FDA priority review for PAH label update after ZENITH trial shows major reduction in serious events and strong clinical impact.
Via
Benzinga
FDA Grants Priority Review for WINREVAIR™ (sotatercept-csrk) to Update Label Based on Results From ZENITH Trial
July 02, 2025
From
Merck & Co., Inc.
Via
Business Wire
MERCK & CO. INC. (NYSE:MRK) – A Strong Value Candidate in Healthcare
July 02, 2025
MERCK & CO. (NYSE:MRK) is an undervalued pharmaceutical stock with strong profitability, a healthy balance sheet, and a reliable dividend, making it a candidate for value investors.
Via
Chartmill
Dogs Of The Dow: How You Can Get Dividend Stocks With Yields Up To 6.3%
July 01, 2025
The Dow Jones Industrial Average stocks average a 2% dividend yield through the first six months of 2025. Here are the top yields.
Via
Benzinga
Topics
Stocks
Dow Jones 2025 First Half Scoreboard: Top 10 Winners, Losers — Where Do Nvidia, Apple Stock Rank?
July 01, 2025
The Dow Jones Industrial Average was up around 4% in the first half of 2025 with a large majority of the 30 stocks positive.
Via
Benzinga
Topics
Stocks
Merck to Hold Second-Quarter 2025 Sales and Earnings Conference Call July 29
July 01, 2025
From
Merck & Co., Inc.
Via
Business Wire
HDV Is a Popular Dividend ETF for Passive Income. But Is It the Best?
July 01, 2025
Via
The Motley Fool
Topics
Artificial Intelligence
ETFs
Stocks
Can Protagonist Take On Eli Lilly's Next-Generation Obesity Treatment?
June 30, 2025
The company announced a new drug that uses the same mechanism as Eli Lilly's retatrutide.
Via
Investor's Business Daily
Peering Into Merck & Co's Recent Short Interest
June 30, 2025
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.